组蛋白修饰调控miRNAs在胰腺癌干细胞干性维持中的作用

基本信息
批准号:81301871
项目类别:青年科学基金项目
资助金额:23.00
负责人:谢桥生
学科分类:
依托单位:中国人民解放军军事科学院军事医学研究院
批准年份:2013
结题年份:2016
起止时间:2014-01-01 - 2016-12-31
项目状态: 已结题
项目参与者:杨武威,李静,祝宝让,郑子瑞,魏从文,盖绿华,刘滢
关键词:
肿瘤干细胞微小RNA干性维持C11_胰肿瘤组蛋白修饰
结项摘要

Cancer stem cell is an initiating factor in pancreatic cancer initiation, progression, metastasis, recurrence, and drug resistance and the maintenance of its stemness is crucial. Pancreatic cancer can be cured by destroying the cancer stem cell, but the molecular mechanisms of stemness maintenance of pancreatic cancer stem cell need to be demonstrated. CXCR4 is the key molecule to maintain the stemness of pancreatic cancer stem cells. Our preliminary research has confirmed that miR-139 and miR-146a can target CXCR4 3`-UTR to inhibit its expression and the acetylating modification state of histone is involved in the regulation of these miRNAs. Based on this, through cytological experiments and tumor-bearing nude mice model, CD133+CXCR4+ pancreatic cancer stem cells will be established to detect the expression of miR-139 and miR-146a, and the histone modification status of these miRNAs gene promoter region. By overexpression of miR-139 and miR-146a in pancreatic cancer stem cell and observing whether miRNAs affects the maintenance of its stemness which includes self-renewal, proliferation, invasion and metastasis, gemcitabine-resistant and high-tumorigenic. It is designed to reveal the role of miRNAs in the maintenance of stemness of pancreatic cancer stem cell, the histone modification mechanism of regulation of miRNAs expression, as well as the new molecular mechanism for stemness maintenance, which can provide a new strategy for pancreatic cancer treatment, and is of important theoretical significance and practical value.

肿瘤干细胞是胰腺癌发生、发展、转移、复发、耐药的始动因素,其干性维持很关键,通过消灭肿瘤干细胞可以治疗胰腺癌,但需要明确胰腺癌干细胞干性维持的分子机制。CXCR4是胰腺癌干细胞干性维持的重要分子,我们前期工作证实miR-139、miR-146a能抑制CXCR4的表达,发现组蛋白乙酰化修饰能调控miRNAs基因表达。在此基础上,我们筛选获得CD133+CXCR4+胰腺癌干细胞,检测细胞中miR-139、miR-146a表达水平及miRNA基因启动子区组蛋白修饰状态;通过在胰腺癌干细胞中过表达miR-139、miR-146a,观察miRNAs是否影响胰腺癌干细胞干性维持:自我更新、生长增殖、侵袭转移、吉西他滨耐药、高致瘤性;旨在揭示胰腺癌干细胞干性维持中miRNAs的作用及其表达调控的组蛋白修饰机制,试图阐明胰腺癌干细胞干性维持的新机制,为治疗胰腺癌提供新策略,具有重要理论意义和实际应用价值。

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

Loss of a Centrosomal Protein,Centlein, Promotes Cell Cycle Progression

DOI:10.16476/j.pibb.2019.0092
发表时间:2019
2

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

Complete loss of RNA editing from the plastid genome and most highly expressed mitochondrial genes of Welwitschia mirabilis

DOI:https://doi.org/10.1007/s11427-018-9450-1
发表时间:2019
3

内质网应激在抗肿瘤治疗中的作用及研究进展

内质网应激在抗肿瘤治疗中的作用及研究进展

DOI:10.3969/j.issn.1001-1978.2021.12.004
发表时间:2021
4

上转换纳米材料在光动力疗法中的研究进展

上转换纳米材料在光动力疗法中的研究进展

DOI:
发表时间:2017
5

高龄妊娠对子鼠海马神经干细胞发育的影响

高龄妊娠对子鼠海马神经干细胞发育的影响

DOI:10.7499/j.issn.1008-8830.2003213
发表时间:2020

谢桥生的其他基金

相似国自然基金

1

lncRNA在神经干细胞干性维持和分化中的作用及调控机制

批准号:31271450
批准年份:2012
负责人:罗玉萍
学科分类:C0703
资助金额:80.00
项目类别:面上项目
2

组蛋白H1调控成体干细胞干性维持的表观遗传机制研究

批准号:31571320
批准年份:2015
负责人:倪建泉
学科分类:C0601
资助金额:65.00
项目类别:面上项目
3

HIF-2α在肺癌干细胞干性维持和放疗抵抗中的作用

批准号:81101701
批准年份:2011
负责人:孙建聪
学科分类:H1821
资助金额:22.00
项目类别:青年科学基金项目
4

FoxM1介导的SCD1高表达在胰腺癌干细胞干性维持中的作用与机制研究

批准号:81402017
批准年份:2014
负责人:孔祥毓
学科分类:H1810
资助金额:23.00
项目类别:青年科学基金项目